Arch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Down 9.6% in November

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 13,200 shares, a drop of 9.6% from the October 31st total of 14,600 shares. Based on an average daily trading volume, of 13,900 shares, the days-to-cover ratio is presently 0.9 days.

Arch Therapeutics Trading Up 6.7 %

Shares of ARTH stock opened at $0.21 on Monday. Arch Therapeutics has a one year low of $0.17 and a one year high of $18.00. The company has a fifty day moving average price of $0.32 and a two-hundred day moving average price of $0.67.

Arch Therapeutics Company Profile

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.